Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Renal Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Renal Diseasemarket, defines the market attractiveness level of Renal Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Renal Disease industry, describes the types of Renal Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Renal Disease market and the development prospects and opportunities of Renal Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Renal Disease market in Chapter 13.
By Player:
Novartis AG (Switzerland)
Bristol-Myers Squibb Company (US)
Shire Pharmaceuticals Limited (Republic of Ireland)
Abbott (US)
Keryx Biopharmaceuticals Inc (US)
Pfizer Inc(US)
Amgen Inc (US)
NephroGenex Inc (US)
Sanofi (France)
Baxter (US)
By Type:
Acute Kidney Problems
Chronic Kidney Diseases
Others
By End-User:
Hospital
Clinic
Research Center
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Renal Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Renal Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Renal Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Renal Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Renal Disease Market Analysis and Outlook to 2022
-
7.1 Global Renal Disease Consumption (2017-2022)
-
7.2 United States Renal Disease Consumption (2017-2022)
-
7.3 Europe Renal Disease Consumption (2017-2022)
-
7.4 China Renal Disease Consumption (2017-2022)
-
7.5 Japan Renal Disease Consumption (2017-2022)
-
7.6 India Renal Disease Consumption (2017-2022)
-
7.7 South Korea Renal Disease Consumption (2017-2022)
8 Region and Country-wise Renal Disease Market Analysis and Outlook to 2028
-
8.1 Global Renal Disease Consumption Forecast (2022-2028)
-
8.2 United States Renal Disease Consumption Forecast (2022-2028)
-
8.3 Europe Renal Disease Consumption Forecast (2022-2028)
-
8.4 China Renal Disease Consumption Forecast (2022-2028)
-
8.5 Japan Renal Disease Consumption Forecast (2022-2028)
-
8.6 India Renal Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Renal Disease Consumption Forecast (2022-2028)
9 Global Renal Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Renal Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Acute Kidney Problems Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chronic Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Renal Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Renal Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Renal Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Acute Kidney Problems Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chronic Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Renal Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Renal Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Renal Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Renal Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Renal Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Renal Disease Market Competitive Analysis
-
14.1 Novartis AG (Switzerland)
-
14.1.1 Novartis AG (Switzerland) Company Details
-
14.1.2 Novartis AG (Switzerland) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG (Switzerland) Renal Disease Product and Service
-
14.2 Bristol-Myers Squibb Company (US)
-
14.2.1 Bristol-Myers Squibb Company (US) Company Details
-
14.2.2 Bristol-Myers Squibb Company (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Company (US) Renal Disease Product and Service
-
14.3 Shire Pharmaceuticals Limited (Republic of Ireland)
-
14.3.1 Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
-
14.3.2 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Product and Service
-
14.4 Abbott (US)
-
14.4.1 Abbott (US) Company Details
-
14.4.2 Abbott (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott (US) Renal Disease Product and Service
-
14.5 Keryx Biopharmaceuticals Inc (US)
-
14.5.1 Keryx Biopharmaceuticals Inc (US) Company Details
-
14.5.2 Keryx Biopharmaceuticals Inc (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Keryx Biopharmaceuticals Inc (US) Renal Disease Product and Service
-
14.6 Pfizer Inc(US)
-
14.6.1 Pfizer Inc(US) Company Details
-
14.6.2 Pfizer Inc(US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Inc(US) Renal Disease Product and Service
-
14.7 Amgen Inc (US)
-
14.7.1 Amgen Inc (US) Company Details
-
14.7.2 Amgen Inc (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Inc (US) Renal Disease Product and Service
-
14.8 NephroGenex Inc (US)
-
14.8.1 NephroGenex Inc (US) Company Details
-
14.8.2 NephroGenex Inc (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 NephroGenex Inc (US) Renal Disease Product and Service
-
14.9 Sanofi (France)
-
14.9.1 Sanofi (France) Company Details
-
14.9.2 Sanofi (France) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi (France) Renal Disease Product and Service
-
14.10 Baxter (US)
-
14.10.1 Baxter (US) Company Details
-
14.10.2 Baxter (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Baxter (US) Renal Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Renal Disease
-
Figure Renal Disease Picture
-
Table Global Renal Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Renal Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Renal Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Renal Disease Consumption by Country (2017-2022)
-
Figure United States Renal Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Renal Disease Consumption and Growth Rate (2017-2022)
-
Figure China Renal Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Renal Disease Consumption and Growth Rate (2017-2022)
-
Figure India Renal Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Renal Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Renal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Renal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Renal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Renal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Renal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Renal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Kidney Problems Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Kidney Problems Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Renal Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Renal Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)
-
Table Novartis AG (Switzerland) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG (Switzerland) Renal Disease Product and Service
-
Table Bristol-Myers Squibb Company (US) (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company (US) Renal Disease Product and Service
-
Table Shire Pharmaceuticals Limited (Republic of Ireland) (Foundation Year, Company Profile and etc.)
-
Table Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Product and Service
-
Table Abbott (US) (Foundation Year, Company Profile and etc.)
-
Table Abbott (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott (US) Renal Disease Product and Service
-
Table Keryx Biopharmaceuticals Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Keryx Biopharmaceuticals Inc (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Keryx Biopharmaceuticals Inc (US) Renal Disease Product and Service
-
Table Pfizer Inc(US) (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc(US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc(US) Renal Disease Product and Service
-
Table Amgen Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc (US) Renal Disease Product and Service
-
Table NephroGenex Inc (US) (Foundation Year, Company Profile and etc.)
-
Table NephroGenex Inc (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table NephroGenex Inc (US) Renal Disease Product and Service
-
Table Sanofi (France) (Foundation Year, Company Profile and etc.)
-
Table Sanofi (France) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi (France) Renal Disease Product and Service
-
Table Baxter (US) (Foundation Year, Company Profile and etc.)
-
Table Baxter (US) Renal Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter (US) Renal Disease Product and Service
-
